From tendon to nerve: An msc for all seasons

Canadian Journal of Physiology and Pharmacology

Volumn 90, Issue 3, 2012, Pages 295-306

  Jamnig, Angelika ^a   Lepperdinger, Günter ^a  

^a ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

Author keywords

Differentiation potential; Mscs; Regeneration; Scaffolds; Spinal cord injury; Tendon injury; Tissue engineering

Indexed keywords

GREEN FLUORESCENT PROTEIN; NESTIN; TISSUE SCAFFOLD;

ARTICLE; BONE REGENERATION; CARTILAGE; CELL CULTURE; CELL DIFFERENTIATION; CELL EXPANSION; CLINICAL RESEARCH; GRAFT VERSUS HOST REACTION; HEART; HUMAN; MESENCHYMAL STEM CELL; NERVE; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REGENERATIVE MEDICINE; SPINAL CORD INJURY; TENDON; TENDON INJURY; TISSUE ENGINEERING; TISSUE REGENERATION;

ANIMALS; CELL DIFFERENTIATION; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; NERVOUS SYSTEM DISEASES; SPINAL CORD INJURIES; TENDON INJURIES; TENDONS; TISSUE ENGINEERING;

EID: 84858011870     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/Y11-109     Document Type: Article

References (87)

1. Asahara, T., Masuda, H., Takahashi, T., Kalka, C., Pastore, C., Silver, M., et al. 1999. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 85(3): 221-228.
2. Aslan, H., Kimelman-bleich, N., Pelled, G., and Gazit, D. 2008. Molecular targets for tendon neoformation. Cell, 118(2): 439-444.
3. Awad, H.A., Boivin, G.P., Dressler, M.R., Smith, F.N.L., Young, R.G., and Butler, D.L. 2003. Repair of patellar tendon injuries using a cell-collagen composite. J. Orthop. Res. 21(3): 420-431. doi:10.1016/S0736-0266(02)00163-8.
4. Ball, L.M., Bernardo, M.E., Roelofs, H., Lankester, A., Cometa, A., Egeler, R.M., et al. 2007. Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. Blood, 110(7): 2764-2767. doi:10.1182/blood-2007-04-087056.
5. Bartholomew, A., Sturgeon, C., Siatskas, M., Ferrer, K., McIntosh, K., Patil, S., et al. 2002. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp. Hematol. 30(1): 42-48. doi:10.1016/S0301-472X(01)00769-X.
6. Bianco, P. 2011. Back to the future: moving beyond "mesenchymal stem cells". J. Cell. Biochem. 112(7): 1713-1721. doi:10.1002/jcb.23103.
7. Bianco, P., and Robey, P.G. 2001. Stem cells in tissue engineering. Nature, 414(6859): 118-121. doi:10.1038/35102181.
8. Brittberg, M. 1999. Autologous chondrocyte transplantation. Clin. Orthop. Relat. Res. 367(367 Suppl): S147-S155. doi:10.1097/00003086-199910001-00016.
9. Callera, F., and do Nascimento, R.X. 2006. Delivery of autologous bone marrow precursor cells into the spinal cord via lumbar puncture technique in patients with spinal cord injury: a preliminary safety study. Exp. Hematol. 34(2): 130-131. doi:10.1016/j.exphem.2005.11.006.
10. Cancedda, R., Dozin, B., Giannoni, P., and Quarto, R. 2003. Tissue engineering and cell therapy of cartilage and bone. Matrix Biol. 22 (1): 81-91. doi:10.1016/S0945-053X(03)00012-X.
11. Caplan, A.I. 1991. Mesenchymal stem cells. J. Orthop. Res. 9(5): 641-650. doi:10.1002/jor.1100090504.
12. Centeno, C.J., Busse, D., Kisiday, J., Keohan, C., Freeman, M., and Karli, D. 2008. Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells. Pain Physician, 11(3): 343-353.
13. Chen, S.L., Fang, W.W., Ye, F., Liu, Y.H., Qian, J., Shan, S.J., et al. 2004. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am. J. Cardiol. 94(1): 92-95. doi:10.1016/j.amjcard.2004.03.034.
14. Chen, F.H., Rousche, K.T., and Tuan, R.S. 2006. Technology Insight: adult stem cells in cartilage regeneration and tissue engineering. Nat. Clin. Pract. Rheumatol. 2(7): 373-382. doi:10.1038/ncprheum0216.
15. Choi, Y.H., Saric, T., Nasseri, B., Huhn, S., Van Linthout, S., Hetzer, R., et al. 2011. Cardiac cell therapies: the next generation. Cardiovasc Ther, 29(1): 2-16. doi:10.1111/j.1755-5922.2010.00191.x.
16. Cohnheim, J. 1867. Über Entzündung und Eiterung. J. Arch. Path. Anat. Physiol. Klin. Med. 40(1-2): 1-79. doi:10.1007/BF02968135.
17. Connick, P., Kolappan, M., Patani, R., Scott, M.A., Crawley, C., He, X.-L., et al. 2011. The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: an open-label pre-test: post-test study with blinded outcome assessments. Trials, 12(1): 62. doi:10.1186/1745-6215-12-62.
18. Constantin, G., Marconi, S., Rossi, B., Angiari, S., Calderan, L., Anghileri, E., et al. 2009. Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis. Stem Cells, 27(10): 2624-2635. doi:10.1002/stem.194.
19. D'Ippolito, G., Diabira, S., Howard, G., Menei, P., Roos, B., and Schiller, P.C. 2004. Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J. Cell Sci. 117(14): 2971-2981. doi:10.1242/jcs.01103.
20. Danielyan, L., Schafer, R., von Ameln-Mayerhofer, A., Bernhard, F., Verleysdonk, S., Buadze, M., et al. 2011. Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease. Rejuvenation Res. 14(1): 3-16. doi:10.1089/rej.2010.1130.
21. Delcroix, G.J., Curtis, K.M., Schiller, P.C., and Montero-Menei, C.N. 2010. EGF and bFGF pre-treatment enhances neural specification and the response to neuronal commitment of MIAMI cells. Differentiation, 80(4-5): 213-227.
22. Deng, J., Petersen, B.E., Steindler, D.A., Jorgensen, M.L., and Laywell, E.D. 2006. Mesenchymal stem cells spontaneously express neural proteins in culture and are neurogenic after transplantation. Stem Cells, 24(4): 1054-1064. doi:10.1634/stemcells.2005-0370.
23. DiGirolamo, C.M., Stokes, D., Colter, D., Phinney, D.G., Class, R., and Prockop, D.J. 1999. Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Br. J. Haematol. 107(2): 275-281. doi:10.1046/j.1365-2141.1999.01715.x.
24. Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., et al. 2006. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8(4): 315-317. doi:10.1080/14653240600855905.
25. Fang, K.-M., Chen, J.-K., Hung, S.-C., Chen, M.-C., Wu, Y.-T., Wu, T.-J., et al. 2010. Effects of combinatorial treatment with pituitary adenylate cyclase activating peptide and human mesenchymal stem cells on spinal cord tissue repair. PLoS ONE, 5(12): e15299. doi:10.1371/journal.pone.0015299.
26. Fehrer, C., Brunauer, R., Laschober, G., Unterluggauer, H., Reitinger, S., Kloss, F., et al. 2007. Reduced oxygen tension attenuates differentiation capacity of human mesenchymal stem cells and prolongs their lifespan. Aging Cell, 6(6): 745-757. doi:10.1111/j.1474-9726.2007.00336.x.
27. Friedenstein, A.J., Chailakhjan, R.K., and Lalykina, K.S. 1970. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet. 3(4): 393-403.
28. Fröhlich, M., Grayson, W.L., Wan, L.Q., Marolt, D., Drobnic, M., and Vunjak-Novakovic, G. 2008. Tissue engineered bone grafts: biological requirements, tissue culture and clinical relevance. Curr. Stem. Cell Res. Ther. 3(4): 254-264.
29. Gerdoni, E., Gallo, B., Casazza, S., Musio, S., Bonanni, I., Pedemonte, E., et al. 2007. Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Ann. Neurol. 61(3): 219-227. doi:10.1002/ana.21076.
30. Hoffmann, A., Pelled, G., Turgeman, G., Eberle, P., Zilberman, Y., Shinar, H., et al. 2006. Neotendon formation induced by manipulation of the Smad8 signalling pathway in mesenchymal stem cells. J. Clin. Invest. 116(4): 940-952. doi:10.1172/JCI22689.
31. Hofstetter, C.P., Schwarz, E.J., Hess, D., Widenfalk, J., El Manira, A., Prockop, D.J., and Olson, L. 2002. Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc. Natl. Acad. Sci. U.S.A. 99(4): 2199-2204. doi:10.1073/pnas.042678299.
32. Honmou, O., Houkin, K., Matsunaga, T., Niitsu, Y., Ishiai, S., Onodera, R., et al. 2011. Intravenous administration of auto serumexpanded autologous mesenchymal stem cells in stroke. Brain, 134(6): 1790-1807. doi:10.1093/brain/awr063.
33. Ichim, T.E., Solano, F., Lara, F., Paris, E., Ugalde, F., Rodriguez, J.P., et al. 2010. Feasibility of combination allogeneic stem cell therapy for spinal cord injury: a case report. Int. Arch. Med. 3(1): 30. doi:10.1186/1755-7682-3-30.
34. Jiang, Y., Vaessen, B., Lenvik, T., Blackstad, M., Reyes, M., and Verfaillie, C.M. 2002. Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp. Hematol. 30(8): 896-904. doi:10.1016/S0301-472X(02)00869-X.
35. Jiang, R., Han, Z., Zhuo, G., Qu, X., Li, X., Wang, X., et al. 2011. Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study. Front. Med. 5(1): 94-100. doi:10.1007/s11684-011-0116-z.
36. Ju, Y.-J., Muneta, T., Yoshimura, H., Koga, H., and Sekiya, I. 2008. Synovial mesenchymal stem cells accelerate early remodeling of tendon-bone healing. Cell Tissue Res. 332(3): 469-478. doi:10.1007/s00441-008-0610-z.
37. Jung, D.-I., Ha, J., Kang, B.-T., Kim, J.-W., Quan, F.-S., Lee, J.-H., et al. 2009. A comparison of autologous and allogenic bone marrowderived mesenchymal stem cell transplantation in canine spinal cord injury. J. Neurol. Sci. 285(1-2): 67-77. doi:10.1016/j.jns.2009.05.027.
38. Karussis, D., Karageorgiou, C., Vaknin-Dembinsky, A., Gowda-Kurkalli, B., Gomori, J.M., Kassis, I., et al. 2010. Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch. Neurol. 67(10): 1187-1194. doi:10.1001/archneurol.2010.248.
39. Kharaziha, P., Hellstrom, P.M., Noorinayer, B., Farzaneh, F., Aghajani, K., Jafari, F., et al. 2009. Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial. Eur. J. Gastroenterol. Hepatol. 21(10): 1199-1205. doi:10.1097/MEG.0b013e32832a1f6c.
40. Klopp, A.H., Gupta, A., Spaeth, E., Andreeff, M., and Marini, F., III. 2011. Concise review: dissecting a discrepancy in the literature: do mesenchymal stem sells support or suppress tumor growth? Stem Cells, 29(1): 11-19. doi:10.1002/stem.559.
41. Koga, H., Shimaya, M., Muneta, T., Nimura, A., Morito, T., Hayashi, M., Suzuki, S., et al. 2008. Local adherent technique for transplanting mesenchymal stem cells as a potential treatment of cartilage defect. Arthritis Res. Ther.10(4): R84.
42. Kon, E., Muraglia, A., Corsi, A., Bianco, P., Marcacci, M., Martin, I., et al. 2000. Autologous bone marrow stromal cells loaded onto porous hydroxyapatite ceramic accelerate bone repair in criticalsize defects of sheep long bones. J. Biomed. Mater. Res. 49(3): 328-337. doi:10.1002/(SICI)1097-4636(20000305)49:3<328::AID-JBM5>3.0.CO;2-Q.
43. Krebsbach, P.H., Kuznetsov, S.A., Satomura, K., Emmons, R.V., Rowe, D.W., and Robey, P.G. 1997. Bone formation in vivo: comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts. Transplantation, 63(8): 1059-1069. doi:10.1097/00007890-199704270-00003.
44. Kronenberg, H.M., and Schipani, E. 2009. Adult mesenchymal stem cells. StemBook. doi:10.3824/stembook.1.38.1.
45. Lai, R.C., Chen, T.S., and Lim, S.K. 2011. Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease. Regen. Med. 6(4): 481-492. doi:10.2217/rme.11.35.
46. Laschober, G.T., Brunauer, R., Jamnig, A., Singh, S., Hafen, U., Fehrer, C., et al. 2011. Age-specific changes of mesenchymal stem cells are paralleled by upregulation of CD106 expression as a response to an inflammatory environment. Rejuvenation Res. 14 (2): 119-131. doi:10.1089/rej.2010.1077.
47. Le Blanc, K., Frassoni, F., Ball, L., Locatelli, F., Roelofs, H., Lewis, I., et al. Developmental Committee of the European Group for Blood and Marrow Transplantation. 2008. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versushost disease: a phase II study. Lancet, 371(9624): 1579-1586. doi:10.1016/S0140-6736(08)60690-X.
48. Lee, J.Y., Zhou, Z., Taub, P.J., Ramcharan, M., Li, Y., Akinbiyi, T., et al. 2011. BMP-12 treatment of adult mesenchymal stem cells in vitro augments tendon-like tissue formation and defect repair in vivo. PLoS ONE, 6(3): e17531. doi:10.1371/journal.pone.0017531.
49. Lepperdinger, G. 2011. Inflammation and mesenchymal stem cell aging. Curr. Opin. Immunol. 23(4): 518-524. doi:10.1016/j.coi.2011.05.007.
50. Liu, Z.-J., Zhuge, Y., and Velazquez, O.C. 2009. Trafficking and differentiation of mesenchymal stem cells. J. Cell. Biochem. 106 (6): 984-991. doi:10.1002/jcb.22091.
51. Longo, U.G., Lamberti, A., Maffulli, N., and Denaro, V. 2011. Tissue engineered biological augmentation for tendon healing: a systematic review. Br. Med. Bull. 98: 31-59.
52. Meijer, G.J., de Bruijn, J.D., Koole, R., and van Blitterswijk, C.A. 2008. Cell based bone tissue engineering in jaw defects. Biomaterials, 29(21): 3053-3061. doi:10.1016/j.biomaterials.2008.03.012.
53. Menasché, P., Hagège, A.A., Scorsin, M., Pouzet, B., Desnos, M., Duboc, D., et al. 2001. Myoblast transplantation for heart failure. Lancet, 357(9252): 279-280. doi:10.1016/S0140-6736(00)03617-5.
54. Méndez-Ferrer, S., Michurina, T.V., Ferraro, F., Mazloom, A.R., Macarthur, B.D., Lira, S.A., et al. 2010. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature, 466(7308): 829-834. doi:10.1038/nature09262.
55. Mohamadnejad, M., Alimoghaddam, K., Mohyeddin-Bonab, M., Bagheri, M., Bashtar, M., Ghanaati, H., et al. 2007. Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis. Arch. Iran Med. 10 (4): 459-466.
56. Mohyeddin-Bonab, M., Mohamad-Hassani, M., Alimoghaddam, K., Sanatkar, M., Gasemi, M., Mirkhani, H., et al. 2007. Autologous in vitro expanded mesenchymal stem cell therapy for human old myocardial infarction. Arch. Iran Med. 10(4): 467-473.
57. Nourissat, G., Diop, A., Maurel, N., Salvat, C., Dumont, S., Pigenet, A., Gosset, M., et al. 2010. Mesenchymal stem cell therapy regenerates the native bone-tendon junction after surgical repair in a degenerative rat model. PLoS One, 18(8): e12248.
58. Ohgushi, H., and Caplan, A.I. 1999. Stem cell technology and bioceramics: from cell to gene engineering. J. Biomed. Mater. Res. 48(6): 913-927. doi:10.1002/(SICI)1097-4636(1999)48:6<913::AID-JBM22>3.0.CO;2-0.
59. Olby, N.J., De Risio, L., Muñana, K.R., Wosar, M.A., Skeen, T.M., Sharp, N.J., and Keene, B.W. 2001. Development of a functional scoring system in dogs with acute spinal cord injuries. Am. J. Vet. Res. 62(10): 1624-1628. doi:10.2460/ajvr.2001.62.1624.
60. Osaka, M., Honmou, O., Murakami, T., Nonaka, T., Houkin, K., Hamada, H., and Kocsis, J.D. 2010. Intravenous administration of mesenchymal stem cells derived from bone marrow after contusive spinal cord injury improves functional outcome. Brain Res.1343: 226-235.
61. Pacini, S., Spinabella, S., Trombi, L., Fazzi, R., Galimberti, S., Dini, F., et al. 2007. Suspension of bone marrow-derived undifferentiated mesenchymal stromal cells for repair of superficial digital flexor tendon in race horses. Tissue Eng. 13(12): 2949-2955. doi:10.1089/ten.2007.0108.
62. Panetta, N.J., Gupta, D.M., and Longaker, M.T. 2010. Bone regeneration and repair. Curr. Stem Cell Res. Ther. 5(2): 122-128. doi:10.2174/157488810791268618.
63. Paul, C., Samdani, A.F., Betz, R.R., Fischer, I., and Neuhuber, B. 2009. Grafting of human bone marrow stromal cells into spinal cord injury: a comparison of delivery methods. Spine, 34(4): 328-334. doi:10.1097/BRS.0b013e31819403ce.
64. Pereira, R.F., Halford, K.W., O'Hara, M.D., Leeper, D.B., Sokolov, B.P., Pollard, M.D., et al. 1995. Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc. Natl. Acad. Sci. U. S.A. 92(11): 4857-4861. doi:10.1073/pnas.92.11.4857.
65. Rastegar, F., Shenaq, D., Huang, J., Zhang, W., Zhang, B.-Q., He, B.-C., et al. 2010. Mesenchymal stem cells: Molecular characteristics and clinical applications. World J. Stem Cells, 2 (4): 67-80. doi:10.4252/wjsc.v2.i4.67.
66. Reyes, M., Lund, T., Lenvik, T., Aguiar, D., Koodie, L., and Verfaillie, C.M. 2001. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood, 98(9): 2615-2625. [Retracted in Blood, vol. 113. 5 March 2009] doi:10.1182/blood.V98.9.2615.
67. Richardson, L.E., Dudhia, J., Clegg, P.D., and Smith, R. 2007. Stem cells in veterinary medicine - attempts at regenerating equine tendon after injury. Trends Biotechnol. 25(9): 409-416. doi:10.1016/j.tibtech.2007.07.009.
68. Ripa, R.S., Haack-Sorensen, M., Wang, Y., Jorgensen, E., Mortensen, S., Bindslev, L., et al. 2007. Bone marrow derived mesenchymal cell nobilization by granulocyte-colony stimulating factor after acute myocardial infarction: results from the Stem Cells in Myocardial Infarction (STEMMI) trial. Circulation, 116(11 Suppl.): I24-I30. doi:10.1161/CIRCULATIONAHA.106.678649.
69. Rosenbaum, A.J., Grande, D., and Dines, J.S. 2008. The use of mesenchymal stem cells in tissue engineering: A global assessment. Organogenesis, 4(1): 23-27.
70. Schmitz, J.P., and Hollinger, J.O. 1986. The critical size defect as an experimental model for craniomandibulofacial nonunions. Clin. Orthop. Relat. Res. (205): 299-308.
71. Schnabel, L.V., Lynch, M.E., van der Meulen, M.C.H., Yeager, A.E., Kornatowski, M.A., and Nixon, A.J. 2009. Mesenchymal stem cells and insulin-like growth factor-I gene-enhanced mesenchymal stem cells improve structural aspects of healing in equine flexor digitorum superficialis tendons. J. Orthop. Res. 27(10): 1392-1398.
72. Shang, A.-J., Hong, S.-Q., Xu, Q., Wang, H.-Y., Yang, Y., Wang, Z.-F., et al. 2011. NT-3-secreting human umbilical cord mesenchymal stromal cell transplantation for the treatment of acute spinal cord injury in rats. Brain Res. 1391: 102-113. doi:10.1016/j.brainres.2011.03.019.
73. Si, Y.-L., Zhao, Y.-L., Hao, H.-J., Fu, X.-B., and Han, W.-D. 2011. MSCs: Biological characteristics, clinical applications and their outstanding concerns. Ageing Res. Rev. 10(1): 93-103. doi:10.1016/j.arr.2010.08.005.
74. Stamm, C., Nasseri, B., Choi, Y.H., and Hetzer, R. 2009. Cell therapy for heart disease: great expectations, as yet unmet. Heart Lung Circ. 18(4): 245-256. doi:10.1016/j.hlc.2008.10.014.
75. Stemberger, S., Jamnig, A., Stefanova, N., Lepperdinger, G., Reindl, M., and Wenning, G.K. 2011. Mesenchymal stem cells in a transgenic mouse model of multiple system atrophy: immunomodulation and neuroprotection. PLoS ONE, 6(5): e19808. doi:10.1371/journal.pone.0019808.
76. Tolar, J., Villeneuve, P., and Keating, A. 2011. Mesenchymal stromal cells for graft-versus-host disease. Hum. Gene Ther. 22(3): 257-262. doi:10.1089/hum.2011.1104.
77. Trento, C., and Dazzi, F. 2010. Mesenchymal stem cells and innate tolerance: biology and clinical applications. Swiss Med. Wkly. 140: w13121.
78. Uccelli, A., Moretta, L., and Pistoia, V. 2008. Mesenchymal stem cells in health and disease. Nat. Rev. Immunol. 8(9): 726-736. doi:10.1038/nri2395.
79. Uccelli, A., Benvenuto, F., Laroni, A., and Giunti, D. 2011. Neuroprotective features of mesenchymal stem cells. Best Pract. Res. Clin. Haematol. 24(1): 59-64. doi:10.1016/j.beha.2011.01.004.
80. Violini, S., Ramelli, P., Pisani, L.F., Gorni, C., and Mariani, P. 2009. Horse bone marrow mesenchymal stem cells express embryo stem cell markers and show the ability for tenogenic differentiation by in vitro exposure tp BMP-12. BMC Cell Biol. 10(1): 29. doi:10.1186/1471-2121-10-29.
81. Wang, F., Yasuhara, T., Shingo, T., Kameda, M., Tajiri, N., Yuan, W.J., et al. 2010. Intravenous administration of mesenchymal stem cells exerts therapeutic effects on Parkinsonian model of rats: focusing on neuroprotective effects of stromal cell-derived factor-1alpha. BMC Neurosci. 11(1): 52. doi:10.1186/1471-2202-11-52.
82. Wollert, K.C., and Drexler, H. 2010. Cell therapy for the treatment of coronary heart disease: a critical appraisal. Nat. Rev. Cardiol. 7(4): 204-215. doi:10.1038/nrcardio.2010.1.
83. Wright, K.T., El Masri, W., Osman, A., Chowdhury, J., and Johnson, W.E.B. 2010. Bone marrow for the treatment of spinal cord injury: mechanisms and clinical application. Stem Cells.
84. Wu, W., Zhao, H., Xie, B., Liu, H., Chen, Y., Jiao, G., and Wang, H. 2011. Implanted spike wave electric stimulation promotes survival of the bone marrow mesenchymal stem cells and functional recovery in the spinal cord injured rats. Neurosci. Lett. 491(1): 73-78. doi:10.1016/j.neulet.2011.01.009.
85. Young, R.G., Butler, D.L., Weber, W., Caplan, A.I., Gordon, S.L., and Fink, D.J. 1998. Use of mesenchymal stem cells in a collagen matrix for Achilles tendon repair. J. Orthop. Res. 16(4): 406-413. doi:10.1002/jor.1100160403.
86. Zappia, E., Casazza, S., Pedemonte, E., Benvenuto, F., Bonanni, I., Gerdoni, E., et al. 2005. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood, 106(5): 1755-1761. doi:10.1182/blood-2005-04-1496.
87. Zhang, X.-y., Russa, V.F.L., Bao, L., Kolls, J., Schwarzenberger, P., and Reiser, J. 2002. Lentiviral vectors for sustained transgene expression in human bone marrow-derived stromal cells. Mol. Ther. 5: 1-3. doi:10.0116/mthe.2002.0585.